Pharmacokinetics and Biotransformation of Beraprost Sodium III:Metabolites in Tissues and Enterohepatic Circulation of Beraprost Sodium in Rat

The metabolites of beraprost sodium in plasma and tissues, and its biliary excretion and enterohepatic circulation were investigated in male and female rats using 3H-labelled substance. The most predominant metabolite, 2, 3-dinor-beraprost was shown to be distributed mainly in the liver. However, th...

Full description

Saved in:
Bibliographic Details
Published inXenobiotic metabolism and disposition Vol. 4; no. 6; pp. 743 - 753
Main Authors YUGE, Takuro, HAMASAKI, Tadashi, TANJI, Shoji, HORIBA, Masahiro, MATSUMOTO, Kazuhisa, TAJIMA, Atsuko, OHNO, Kiyotaka
Format Journal Article
LanguageEnglish
Japanese
Published Japanese Society for the Study of Xenobiotics 1989
Online AccessGet full text

Cover

Loading…
More Information
Summary:The metabolites of beraprost sodium in plasma and tissues, and its biliary excretion and enterohepatic circulation were investigated in male and female rats using 3H-labelled substance. The most predominant metabolite, 2, 3-dinor-beraprost was shown to be distributed mainly in the liver. However, this a-oxidation metabolite was found to be produced in male rats at an apparently higher level than in female rats. On the other hand, as the oxidation of C-15 alcohol is concerned, the females possess higher capacity for this biotransformation process. he study on biliary excretion showed that male rats could excrete more drug, principally as 2, 3-dinor-beraprost, into the bile compared to the female rats. This sex difference in biliary excretion was facilitated by the following enterohepatic circulation. As a result, urinary excretion of beraprost sodium in female rats attained nearly four times of that in male rats. All these results seem to be basically related to the difference in n-oxidation capacity in the liver of both sexes.
ISSN:0916-1139
DOI:10.2133/dmpk.4.743